Drug Side Effects
Search
SARS-COV-2 VIRAEMIA
SARS-COV-2 VIRAEMIA
was reported 58 times
SARS-COV-2 VIRAEMIA is most prevalent among patients taking these drug classes:
#
Drug class
Count
Frequency
0
SARS-CoV-2 Nucleotide Analog RNA Polymerase Inhibitor [EPC]
12
0.0009
1
Human alpha-1 Proteinase Inhibitor [EPC]
1
0.0002
2
Cytomegalovirus Nucleoside Analog DNA Polymerase Inhibitor [EPC]
2
0.0001
3
Protease Inhibitor [EPC]
3
0.0001
4
CD20-directed Cytolytic Antibody [EPC]
16
0.0001
5
Cytochrome P450 3A Inhibitor [EPC]
3
0.0000
6
Corticosteroid [EPC]
42
0.0000
7
Penem Antibacterial [EPC]
1
0.0000
8
Aminoglycoside Antibacterial [EPC]
1
0.0000
9
Nitroimidazole Antimicrobial [EPC]
1
0.0000
10
Alkylating Drug [EPC]
3
0.0000
11
Nucleoside Analog Antiviral [EPC]
1
0.0000
12
Herpesvirus Nucleoside Analog DNA Polymerase Inhibitor [EPC]
1
0.0000
13
Herpes Simplex Virus Nucleoside Analog DNA Polymerase Inhibitor [EPC]
1
0.0000
14
Calcineurin Inhibitor Immunosuppressant [EPC]
1
0.0000
15
Nucleoside Metabolic Inhibitor [EPC]
2
0.0000
16
Interleukin-6 Receptor Antagonist [EPC]
1
0.0000
17
Azole Antifungal [EPC]
1
0.0000
18
Janus Kinase Inhibitor [EPC]
1
0.0000
19
Dihydropyridine Calcium Channel Blocker [EPC]
2
0.0000
20
Folate Analog Metabolic Inhibitor [EPC]
2
0.0000
21
Kinase Inhibitor [EPC]
1
0.0000
22
Tumor Necrosis Factor Blocker [EPC]
1
0.0000